These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 29533533)
21. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Le Blanc K; Frassoni F; Ball L; Locatelli F; Roelofs H; Lewis I; Lanino E; Sundberg B; Bernardo ME; Remberger M; Dini G; Egeler RM; Bacigalupo A; Fibbe W; Ringdén O; Lancet; 2008 May; 371(9624):1579-86. PubMed ID: 18468541 [TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease: a report of two cases. Lim JH; Lee MH; Yi HG; Kim CS; Kim JH; Song SU Int J Hematol; 2010 Jul; 92(1):204-7. PubMed ID: 20514533 [TBL] [Abstract][Full Text] [Related]
23. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568 [TBL] [Abstract][Full Text] [Related]
24. [Mesenchymal stem cells for treatment of graft-versus-host disease]. Najima Y Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881 [TBL] [Abstract][Full Text] [Related]
25. The efficiency of human umbilical cord mesenchymal stem cells as a salvage treatment for steroid-refractory acute graft-versus-host disease. Ding Y; Liu C; Cai Y; Hou C; Chen G; Xu Y; Hu S; Wu D Clin Exp Med; 2023 Oct; 23(6):2561-2570. PubMed ID: 36598673 [TBL] [Abstract][Full Text] [Related]
26. Repeated Infusions of Bone-Marrow-Derived Mesenchymal Stem Cells over 8 Weeks for Steroid-Refractory Chronic Graft-versus-Host Disease: A Prospective, Phase I/II Clinical Study. Kim N; Min GJ; Im KI; Nam YS; Song Y; Lee JS; Oh EJ; Chung NG; Jeon YW; Lee JW; Cho SG Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928436 [TBL] [Abstract][Full Text] [Related]
27. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia. Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100 [TBL] [Abstract][Full Text] [Related]
28. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856 [TBL] [Abstract][Full Text] [Related]
35. Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. Kallekleiv M; Larun L; Bruserud Ø; Hatfield KJ Cytotherapy; 2016 Feb; 18(2):172-85. PubMed ID: 26794711 [TBL] [Abstract][Full Text] [Related]
36. Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation. Gao L; Zhang Y; Hu B; Liu J; Kong P; Lou S; Su Y; Yang T; Li H; Liu Y; Zhang C; Gao L; Zhu L; Wen Q; Wang P; Chen X; Zhong J; Zhang X J Clin Oncol; 2016 Aug; 34(24):2843-50. PubMed ID: 27400949 [TBL] [Abstract][Full Text] [Related]
37. Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. Introna M; Lucchini G; Dander E; Galimberti S; Rovelli A; Balduzzi A; Longoni D; Pavan F; Masciocchi F; Algarotti A; Micò C; Grassi A; Deola S; Cavattoni I; Gaipa G; Belotti D; Perseghin P; Parma M; Pogliani E; Golay J; Pedrini O; Capelli C; Cortelazzo S; D'Amico G; Biondi A; Rambaldi A; Biagi E Biol Blood Marrow Transplant; 2014 Mar; 20(3):375-81. PubMed ID: 24321746 [TBL] [Abstract][Full Text] [Related]
38. The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature. Munneke JM; Spruit MJ; Cornelissen AS; van Hoeven V; Voermans C; Hazenberg MD Transplantation; 2016 Nov; 100(11):2309-2314. PubMed ID: 26714122 [TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial. Fu H; Sun X; Lin R; Wang Y; Xuan L; Yao H; Zhang Y; Mo X; Lv M; Zheng F; Kong J; Wang F; Yan C; Han T; Chen H; Chen Y; Tang F; Sun Y; Chen Y; Xu L; Liu K; Zhang X; Liu Q; Huang X; Zhang X BMC Med; 2024 Feb; 22(1):85. PubMed ID: 38413930 [TBL] [Abstract][Full Text] [Related]
40. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation. Tian Y; Deng YB; Huang YJ; Wang Y Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]